DOI QR코드

DOI QR Code

Overexpression of Long Non-Coding RNA HOTAIR Promotes Tumor Growth and Metastasis in Human Osteosarcoma

  • Wang, Bo (Department of Spine Surgery, First Affiliated Hospital of Dalian Medical University) ;
  • Su, Yun (Department of Orthopeadics, Affiliated Zhongshan Hospital of Dalian University) ;
  • Yang, Qun (Department of Spine Surgery, First Affiliated Hospital of Dalian Medical University) ;
  • Lv, Decheng (Department of Spine Surgery, First Affiliated Hospital of Dalian Medical University) ;
  • Zhang, Weiguo (Department of Spine Surgery, First Affiliated Hospital of Dalian Medical University) ;
  • Tang, Kai (Department of Spine Surgery, First Affiliated Hospital of Dalian Medical University) ;
  • Wang, Hong (Department of Spine Surgery, First Affiliated Hospital of Dalian Medical University) ;
  • Zhang, Rui (Department of Spine Surgery, First Affiliated Hospital of Dalian Medical University) ;
  • Liu, Yang (Department of Spine Surgery, First Affiliated Hospital of Dalian Medical University)
  • Received : 2014.11.21
  • Accepted : 2015.01.26
  • Published : 2015.05.31

Abstract

Human osteosarcoma usually presented a high tendency to metastatic spread and caused poor outcomes, however, the underlying mechanism was still largely unknown. In the present study, using a series of in vitro experiments and an animal model, we investigated the roles of HOX antisense intergenic RNA (HOTAIR) during the proliferation and invasion of osteosarcoma. According with our results, HOTAIR was commonly overexpressed in osteosarcoma, which significantly correlated with advanced tumor stage, highly histological grade and poor prognosis. In vitro and in vivo experiments demonstrated that knockdown of HOTAIR could notably suppress cellular proliferation, inhibit invasion and decrease the secretion of MMP2 and MMP9 in osteosarcoma. Collectively, our results suggested that HOTAIR might be a potent therapeutic target for osteosarcoma.

Keywords

References

  1. Bacci, G., Rocca, M., Salone, M., Balladelli, A., Ferrari, S., Palmerini, E., Forni, C., and Briccoli, A. (2008). High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J. Surg. Oncol. 98, 415-420. https://doi.org/10.1002/jso.21140
  2. Bielack, S., Carrle, D., Casali, P.G., and Group, E.G.W. (2009). Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann. Oncol. 20 Suppl 4, 137-139. https://doi.org/10.1093/annonc/mdn526
  3. Bielack, S.S., Kempf-Bielack, B., Delling, G., Exner, G.U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002). Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J. Clin. Oncol. 20, 776-790. https://doi.org/10.1200/JCO.20.3.776
  4. Cho, H.J., Lee, T.S., Park, J.B., Park, K.K., Choe, J.Y., Sin, D.I., Park, Y.Y., Moon, Y.S., Lee, K.G., Yeo, J.H., et al. (2007). Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. J. Biochem. Mol. Biol. 40, 1069-1076. https://doi.org/10.5483/BMBRep.2007.40.6.1069
  5. Davies, K.J. (2014). The complex interaction of matrix metalloproteinases in the migration of cancer cells through breast tissue stroma. Int. J. Breast Cancer 2014, 839094.
  6. Eccles, S.A., and Welch, D.R. (2007). Metastasis: recent discoveries and novel treatment strategies. Lancet 369, 1742-1757. https://doi.org/10.1016/S0140-6736(07)60781-8
  7. Endo, H., Shiroki, T., Nakagawa, T., Yokoyama, M., Tamai, K., Yamanami, H., Fujiya, T., Sato, I., Yamaguchi, K., Tanaka, N., et al. (2013). Enhanced expression of long non-coding RNA HOTAIR is associated with the development of gastric cancer. PLoS One 8, e77070. https://doi.org/10.1371/journal.pone.0077070
  8. Ernst, C., and Morton, C.C. (2013). Identification and function of long non-coding RNA. Front. Cell. Neurosci. 7, 168.
  9. Gibb. E.A., Brown. C.J., and Lam. W.L. (2011). The functional role of long non-coding RNA in human carcinomas. Mol. Cancer 10, 38. https://doi.org/10.1186/1476-4598-10-38
  10. Gupta, R.A., Shah, N., Wang, K.C., Kim ,J., Horlings, H.M., Wong, D.J., Tsai, M.C., Hung, T., Argani, P., Rinn, J.L., et al. (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076. https://doi.org/10.1038/nature08975
  11. Hajjari, M., Behmanesh, M., Sadeghizadeh, M., and Zeinoddini, M. (2013). Up-regulation of HOTAIR long non-coding RNA in human gastric adenocarcinoma tissues. Med. Oncol. 30, 670. https://doi.org/10.1007/s12032-013-0670-0
  12. Han, J., Yong, B., Luo, C., Tan, P., Peng, T., and Shen, J. (2012). High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China. World J. Surg. Oncol. 10, 37. https://doi.org/10.1186/1477-7819-10-37
  13. Hanahan, D., and Weinberg, R.A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674. https://doi.org/10.1016/j.cell.2011.02.013
  14. Gupta, A., Kaur, C.D., Jangdey, M., and Saraf, S. (2014). Matrix metalloproteinase enzymes and their naturally derived inhibitors: novel targets in photocarcinoma therapy. Ageing Res. Reviews 13, 65-74. https://doi.org/10.1016/j.arr.2013.12.001
  15. Himelstein, B.P., Asada, N., Carlton, M.R., and Collins, M.H. (1998). Matrix metalloproteinase-9 (MMP-9) expression in childhood osseous osteosarcoma. Med. Pediatr. Oncol. 31, 471-474. https://doi.org/10.1002/(SICI)1096-911X(199812)31:6<471::AID-MPO2>3.0.CO;2-M
  16. Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M.J., Kenzelmann-Broz, D., Khalil, A.M., Zuk, O., Amit, I., Rabani, M., et al. (2010). A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142, 409-419. https://doi.org/10.1016/j.cell.2010.06.040
  17. Hughes, D.P. (2009). Strategies for the targeted delivery of therapeutics for osteosarcoma. Expert Opin. Drug Del. 6, 1311-1321. https://doi.org/10.1517/17425240903280422
  18. Ishibashi, M., Kogo, R., Shibata, K., Sawada, G., Takahashi, Y., Kurashige, J., Akiyoshi, S., Sasaki, S., Iwaya, T., Sudo, T., et al. (2013). Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncol. Rep. 29, 946-950. https://doi.org/10.3892/or.2012.2219
  19. Kapranov, P., Cheng, J., Dike, S., Nix, D.A., Duttagupta, R., Willingham, A.T., Stadler, P.F., Hertel, J., Hackermuller, J., Hofacker, I.L., et al. (2007). RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316, 1484-1488. https://doi.org/10.1126/science.1138341
  20. Kashima, T., Nakamura, K., Kawaguchi, J., Takanashi, M., Ishida, T., Aburatani, H., Kudo, A., Fukayama, M., and Grigoriadis, A.E. (2003). Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo. Int. J. Cancer 104, 147-154. https://doi.org/10.1002/ijc.10931
  21. Khalil, A.M., Guttman, M., Huarte, M., Garber, M., Raj, A., Rivea, Morales, D., Thomas, K., Presser, A., Bernstein, B.E., van Oudenaarden, A., et al. (2009). Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. USA 106, 11667-11672. https://doi.org/10.1073/pnas.0904715106
  22. Kim, K., Jutooru, I., Chadalapaka, G., Johnson, G., Frank, J., Burghardt, R., Kim, S., and Safe, S. (2013). HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 32, 1616-1625. https://doi.org/10.1038/onc.2012.193
  23. Li, J., Wang, Y., Yu, J., Dong, R., and Qiu, H. (2014). A high level of circulating HOTAIR is associated with progression and poor prognosis of cervical cancer. Tumour Biol. [Epub ahead of print].
  24. Li, X., Wu, Z., Mei, Q., Li, X., Guo, M., Fu, X., and Han, W. (2013). Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma. Br. J. Cancer 109, 2266-2278. https://doi.org/10.1038/bjc.2013.548
  25. Liu, X.H., Liu, Z.L., Sun, M., Liu, J., Wang, Z.X., and De, W. (2013). The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer 13, 464. https://doi.org/10.1186/1471-2407-13-464
  26. Lipovich, L., Johnson, R., and Lin, C.Y. (2010). MacroRNA underdogs in a microRNA world: evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA. Biochim. Biophys. Acta 1799, 597-615. https://doi.org/10.1016/j.bbagrm.2010.10.001
  27. Liu, X.H., Sun, M., Nie, F.Q., Ge, Y.B., Zhang, E.B., Yin, D.D., Kong, R., Xia, R., Lu, K.H., Li, J.H., et al. (2014). Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol. Cancer 13, 92. https://doi.org/10.1186/1476-4598-13-92
  28. Lu, L., Zhu, G., Zhang, C., Deng, Q., Katsaros, D., Mayne, S.T., Risch, H.A., Mu, L., Canuto, E.M., Gregori, G., et al. (2012). Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer. Breast Cancer Res. Treat. 136, 875-883. https://doi.org/10.1007/s10549-012-2314-z
  29. Ma, J.F., Liu, L., Yang, W.J., Zang, L.N., and Xi, Y.M. (2013). RNAimediated knockdown of relaxin decreases in vitro proliferation and invasiveness of osteosarcoma MG-63 cells by inhibition of MMP-9. Eur. Rev. Med. Pharmacol. Sci. 17, 1102-1109.
  30. Matouk, I.J., DeGroot, N., Mezan, S., Ayesh, S., Abu-lail, R., Hochberg, A., and Galun, E. (2007). The H19 non-coding RNA is essential for human tumor growth. PLoS One 2, e845. https://doi.org/10.1371/journal.pone.0000845
  31. Mercer, T.R., Dinger, M.E., and Mattick, J.S. (2009). Long noncoding RNAs: insights into functions. Nat. Rev. Genet. 10, 155-159. https://doi.org/10.1038/nrg2521
  32. Messerschmitt, P.J., Garcia, R.M., Abdul-Karim, F.W., Greenfield, E.M., and Getty, P.J. (2009). Osteosarcoma. J. Am. Acad. Orthopaedic Surg. 17, 515-527. https://doi.org/10.5435/00124635-200908000-00005
  33. Mialou, V., Philip, T., Kalifa, C., Perol, D., Gentet, J.C., Marec- Berard, P., Pacquement, H., Chastagner, P., Defaschelles, A.S., and Hartmann, O. (2005). Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience. Cancer 104, 1100-1109. https://doi.org/10.1002/cncr.21263
  34. Nie, F., Sun, M., Yang, J., Xie, M., Xu, T., Xia, R., Liu, Y., Liu, X., Zhang, E., Lu, K., et al. (2014). Long noncoding RNA ANRIL promotes non small cell lung cancer cells proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Mol. Cancer Ther. 14, 268-277].
  35. Mirabello, L., Troisi, R.J., and Savage, S.A. (2009). Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer, 115, 1531-1543. https://doi.org/10.1002/cncr.24121
  36. Padua, Alves C., Fonseca, A.S., Muys, B.R., de Barros, E.L.B.R., Burger, M.C., de Souza, J.E., Valente, V., Zago, M.A., and Silva, W.A. Jr. (2013). Brief report: the lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines. Stem Cells 31, 2827-2832. https://doi.org/10.1002/stem.1547
  37. Pandey, G.K., Mitra, S., Subhash, S., Hertwig, F., Kanduri, M., Mishra, K., Fransson, S., Ganeshram, A., Mondal, T., Bandaru, S., et al. (2014). The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation. Cancer Cell 26, 722-737. https://doi.org/10.1016/j.ccell.2014.09.014
  38. Pasic, I., Shlien, A., Durbin, A.D., Stavropoulos, D.J., Baskin, B., Ray, P.N., Novokmet, A., and Malkin, D. (2010). Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res. 70, 160-171.
  39. Peng, T.S., Qiu, J.S., Wu, H.X., Liang, H.Z., and Luo, C.Q. (2002). Expressions of CD44s, MMP-9, and Ki-67: possible association with invasion, metastasis, and recurrence of osteosarcoma. Ai Zheng 21, 745-750.
  40. Ponting, C.P., Oliver, P.L., and Reik, W. (2009). Evolution and functions of long noncoding RNAs. Cell 136, 629-641. https://doi.org/10.1016/j.cell.2009.02.006
  41. PosthumaDeBoer, J., Witlox, M.A., Kaspers, G.J., and van Royen, B.J. (2011). Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature. Clin. Exp. Metastasis 28, 493-503 https://doi.org/10.1007/s10585-011-9384-x
  42. Qiu, J.J., Lin, Y.Y., Ye, L.C., Ding, J.X., Feng, W.W., Jin, H.Y., Zhang, Y., Li ,Q., and Hua, K.Q. (2014). Overexpression of long noncoding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Gynecol. Oncol. 134, 121-128. https://doi.org/10.1016/j.ygyno.2014.03.556
  43. Rinn, J.L, Kertesz, M., Wang, J.K., Squazzo, S.L., Xu, X., Brugmann, S.A., Goodnough, L.H., Helms, J.A., Farnham, P.J., Segal, E., et al. (2007). Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311-1323. https://doi.org/10.1016/j.cell.2007.05.022
  44. Ritter, J., and Bielack, S.S. (2010). Osteosarcoma. Ann. Oncol. 21 Suppl 7, vii320-325.
  45. Siclar,i V.A., and Qin, L. (2010). Targeting the osteosarcoma cancer stem cell. J. Orthopaedic Surg. Res. 5, 78. https://doi.org/10.1186/1749-799X-5-78
  46. Sorensen, K.P., Thomassen, M., Tan, Q., Bak, M., Cold, S., Burton, M., Larsen, M.J., and Kruse, T.A. (2013). Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Res. Treat. 142, 529-536. https://doi.org/10.1007/s10549-013-2776-7
  47. Steeg, P.S. (2006). Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 12, 895-904. https://doi.org/10.1038/nm1469
  48. Tsai, M.C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J.K., Lan, F., Shi, Y., Segal, E., and Chang, H.Y. (2010). Long noncoding RNA as modular scaffold of histone modification complexes. Science 329, 689-693. https://doi.org/10.1126/science.1192002
  49. Worth, L.L, Lafleur, E.A., Jia, S.F., and Kleinerman, E.S. (2002). Fas expression inversely correlates with metastatic potential in osteosarcoma cells. Oncol. Rep. 9, 823-827.
  50. Wu, Z.H., Wang, X.L., Tang, H.M., Jiang, T., Chen, J., Lu, S., Qiu, G.Q., Peng, Z.H., and Yan, D.W. (2014). Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer. Oncol. Rep. 32, 395-402. https://doi.org/10.3892/or.2014.3186
  51. Xu, Z.Y., Yu, Q.M., Du, Y.A., Yang, L.T., Dong, R.Z., Huang, L., Yu, P.F., and Cheng, X.D. (2013). Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int. J. Biol. Sci. 9, 587-597. https://doi.org/10.7150/ijbs.6339
  52. Xue, Y., Ma, G., Zhang, Z., Hua, Q., Chu, H., Tong, N., Yuan, L., Qin, C., Yin, C., Zhang, Z., et al. (2014). A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer. Oncotarget 6, 484-493.
  53. Zhang, J., Zhu, X., Li, H., Li, B., Sun, L., Xie, T., Zhu, T., Zhou, H., and Ye, Z. (2015). Piperine inhibits proliferation of human osteosarcoma cells via G2/M phase arrest and metastasis by suppressing MMP-2/-9 expression. Int. Immunopharmacol. 24, 50-58. https://doi.org/10.1016/j.intimp.2014.11.012
  54. Zhang, Q., Geng, P.L., Yin, P., Wang, X.L., Jia, J.P., and Yao, J. (2013). Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis. Asian Pac. J. Cancer Prev. 14, 2311-2315. https://doi.org/10.7314/APJCP.2013.14.4.2311

Cited by

  1. LncRNA ODRUL Contributes to Osteosarcoma Progression through the miR-3182/MMP2 Axis 2017, https://doi.org/10.1016/j.ymthe.2017.06.027
  2. P50-associated COX-2 extragenic RNA (PACER) overexpression promotes proliferation and metastasis of osteosarcoma cells by activating COX-2 gene vol.37, pp.3, 2016, https://doi.org/10.1007/s13277-015-3838-8
  3. Potentials of Long Noncoding RNAs (LncRNAs) in Sarcoma: From Biomarkers to Therapeutic Targets vol.18, pp.4, 2017, https://doi.org/10.3390/ijms18040731
  4. Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer vol.6, pp.10, 2015, https://doi.org/10.1038/cddis.2015.269
  5. Role of Long Noncoding RNA HOTAIR in the Growth and Apoptosis of Osteosarcoma Cell MG-63 vol.2016, 2016, https://doi.org/10.1155/2016/5757641
  6. The emerging role of long noncoding RNAs in oral cancer vol.123, pp.2, 2017, https://doi.org/10.1016/j.oooo.2016.10.006
  7. Discovery of a novel genetic susceptibility locus on X chromosome for systemic lupus erythematosus vol.17, pp.1, 2015, https://doi.org/10.1186/s13075-015-0857-1
  8. Long Noncoding RNAs Regulate Cell Growth, Proliferation, and Apoptosis vol.35, pp.9, 2016, https://doi.org/10.1089/dna.2015.3187
  9. Long noncoding RNAs in gastric cancer carcinogenesis and metastasis 2016, https://doi.org/10.1093/bfgp/elw011
  10. Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma vol.7, pp.9, 2016, https://doi.org/10.1038/cddis.2016.272
  11. Emerging roles for long noncoding RNAs in skeletal biology and disease vol.58, pp.1, 2017, https://doi.org/10.1080/03008207.2016.1194406
  12. The lncRNA HOTAIR impacts on mesenchymal stem cellsviatriple helix formation vol.44, pp.22, 2016, https://doi.org/10.1093/nar/gkw802
  13. Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth vol.8, pp.2, 2017, https://doi.org/10.1038/cddis.2017.31
  14. Genetic factors conferring metastasis in osteosarcoma vol.12, pp.13, 2016, https://doi.org/10.2217/fon-2016-0014
  15. Histone methylase MLL1 coordinates with HIF and regulate lncRNA HOTAIR expression under hypoxia vol.629, 2017, https://doi.org/10.1016/j.gene.2017.07.069
  16. Understanding the Functions of Long Non-Coding RNAs through Their Higher-Order Structures vol.17, pp.5, 2016, https://doi.org/10.3390/ijms17050702
  17. Upregulation of microRNA-25-3p inhibits proliferation, migration and invasion of osteosarcoma cells in vitro by directly targeting SOX4 vol.16, pp.4, 2017, https://doi.org/10.3892/mmr.2017.7103
  18. Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis vol.51, pp.5, 2017, https://doi.org/10.3892/ijo.2017.4127
  19. Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments? pp.1744-8352, 2018, https://doi.org/10.1080/14737159.2018.1535903
  20. HOTAIR promotes osteosarcoma development by sponging miR-217 and targeting ZEB1 pp.00219541, 2018, https://doi.org/10.1002/jcp.27394
  21. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-29737-4
  22. HOTAIR induces the ubiquitination of Runx3 by interacting with Mex3b and enhances the invasion of gastric cancer cells vol.21, pp.5, 2018, https://doi.org/10.1007/s10120-018-0801-6
  23. From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma pp.1573-7233, 2018, https://doi.org/10.1007/s10555-018-9763-8
  24. LncRNA LINC00880 promotes cell proliferation, migration, and invasion while inhibiting apoptosis by targeting CACNG5 through the MAPK signaling pathway in spinal cord ependymoma vol.233, pp.9, 2018, https://doi.org/10.1002/jcp.26329
  25. Targeted design and identification of AC1NOD4Q to block activity of HOTAIR by abrogating the scaffold interaction with EZH2 vol.11, pp.1, 2019, https://doi.org/10.1186/s13148-019-0624-2
  26. MEG3: an Oncogenic Long Non-coding RNA in Different Cancers pp.1532-2807, 2019, https://doi.org/10.1007/s12253-019-00614-3
  27. MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A vol.7, pp.34, 2015, https://doi.org/10.18632/oncotarget.10752
  28. Overexpression of long noncoding RNA HOTTIP promotes tumor invasion and predicts poor prognosis in gastric cancer vol.9, pp.None, 2015, https://doi.org/10.2147/ott.s95414
  29. Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP vol.10, pp.None, 2015, https://doi.org/10.2147/ott.s112686
  30. Long non-coding RNAs in osteosarcoma vol.8, pp.12, 2015, https://doi.org/10.18632/oncotarget.14726
  31. Antisense lncRNA FOXF1-AS1 Promotes Migration and Invasion of Osteosarcoma Cells Through the FOXF1/MMP-2/-9 Pathway vol.13, pp.9, 2015, https://doi.org/10.7150/ijbs.21722
  32. Targeting the long noncoding RNA MALAT1 blocks the pro-angiogenic effects of osteosarcoma and suppresses tumour growth vol.13, pp.11, 2017, https://doi.org/10.7150/ijbs.22249
  33. Long non-coding RNAs for osteosarcoma in the mouse: a meta-analysis vol.8, pp.59, 2017, https://doi.org/10.18632/oncotarget.20128
  34. Long noncoding RNA HOTAIR promotes the proliferation and metastasis of osteosarcoma cells through the AKT/mTOR signaling pathway vol.14, pp.6, 2015, https://doi.org/10.3892/etm.2017.5248
  35. Long Non-Coding RNA HULC Promotes Progression of Bone Neoplasms vol.24, pp.None, 2015, https://doi.org/10.12659/msm.910220
  36. Long non-coding RNA XIST as a potential prognostic biomarker in human cancers: a meta-analysis vol.9, pp.17, 2015, https://doi.org/10.18632/oncotarget.23744
  37. Long non-coding RNA phosphatase and tensin homolog pseudogene 1 suppresses osteosarcoma cell growth via the phosphoinositide 3-kinase/protein kinase B signaling pathway vol.15, pp.6, 2015, https://doi.org/10.3892/etm.2018.6021
  38. Identification of biomarkers associated with the recurrence of osteosarcoma using ceRNA regulatory network analysis vol.43, pp.4, 2019, https://doi.org/10.3892/ijmm.2019.4108
  39. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma vol.120, pp.8, 2015, https://doi.org/10.1002/jcb.28514
  40. LncRNA, Important Player in Bone Development and Disease vol.20, pp.1, 2015, https://doi.org/10.2174/1871530319666190904161707
  41. Effects of lncRNA TUSC7 on the malignant biological behavior of osteosarcoma cells via regulation of miR-375 vol.20, pp.5, 2020, https://doi.org/10.3892/ol.2020.11994
  42. LINC00657 activates PD‐L1 to promote osteosarcoma metastasis via miR‐106a vol.121, pp.10, 2015, https://doi.org/10.1002/jcb.29574
  43. Long Noncoding RNA HCG9 Promotes Osteosarcoma Progression through RAD51 by Acting as a ceRNA of miR-34b-3p vol.2021, pp.None, 2021, https://doi.org/10.1155/2021/9978882
  44. Functional Interaction among lncRNA HOTAIR and MicroRNAs in Cancer and Other Human Diseases vol.13, pp.3, 2015, https://doi.org/10.3390/cancers13030570
  45. Osteosarcoma and Metastasis vol.11, pp.None, 2015, https://doi.org/10.3389/fonc.2021.780264
  46. Long noncoding RNA-miRNA-mRNA axes multiple roles in osteosarcoma vol.23, pp.None, 2015, https://doi.org/10.1016/j.genrep.2021.101090
  47. Genome-wide analyses of XRN1-sensitive targets in osteosarcoma cells identify disease-relevant transcripts containing G-rich motifs vol.27, pp.10, 2015, https://doi.org/10.1261/rna.078872.121